PALVELLA THERAPEUTICS, INC. (PVLA): restructuring charge — Pieris adds $3.4M retention & severance costs to July 2023 restructuring estimate

PALVELLA THERAPEUTICS, INC.

Compensation Committee approved retention benefits for non-executive employees on Aug 30, 2023.
Total estimated retention, severance and related costs now ~$3.4M through Q2 2024.
This amount is in addition to severance costs originally reported in the July 18, 2023 8-K.
Amendment filed solely to update cost estimates; no other changes to prior disclosures.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

PALVELLA THERAPEUTICS, INC. announced a restructuring with charges of approximately $3.4 million affecting Workplace Restructuring.

Type: restructuring
Charge: approximately $3.4 million
Affected area: Workplace Restructuring

Exact text from the filing

As a result of the Workplace Restructuring, the Company expects to incur estimated retention benefits, severance and related costs of approximately $3.4 million through the second quarter of 2024.

View on SEC.gov

7 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

PALVELLA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-024952

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.